Next Century Growth Investors LLC Guardant Health, Inc. Transaction History

Next Century Growth Investors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$99.96 - $135.93 $2.02 Million - $2.74 Million	-20,167 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$80.32 - $111.8 $90,119 - $125,439	-1,122 Reduced 5.27%	20,167 $2.25 Million
Q2 2020 Aug 14, 2020	SELL	$60.49 - $97.5 $4,960 - $7,995	-82 Reduced 0.38%	21,289 $1.73 Million
Q1 2020 May 14, 2020	BUY	$59.04 - $88.81 $177 - $266	3 Added 0.01%	21,371 $1.49 Million
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $20,583 - $28,641	-346 Reduced 1.59%	21,368 $1.67 Million
Q3 2019 Nov 14, 2019	SELL	$62.59 - $110.3 $581,899 - $1.03 Million	-9,297 Reduced 29.98%	21,714 $1.39 Million
Q2 2019 Aug 14, 2019	SELL	$63.94 - $91.11 $9,654 - $13,757	-151 Reduced 0.48%	31,011 $2.68 Million
Q1 2019 May 14, 2019	SELL	$34.3 - $97.98 $1.14 Million - $3.27 Million	-33,338 Reduced 51.69%	31,162 $2.39 Million
Q4 2018 Feb 14, 2019	BUY	$29.2 - $46.1 $1.88 Million - $2.97 Million	64,500 New	64,500 $2.42 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Next Century Growth Investors LLC with notifications on news.